Back to Journals » HIV/AIDS - Research and Palliative Care » Volume 11

Diagnostic accuracy of HIV test kits, Genscreen Ultra and Bioelisa

Authors Abrahim SA, Girma M, Habteselassie A, Gezahegn N, Feleke A, Berheto TM, Demissie M, Belete W, Deressa T

Received 23 August 2018

Accepted for publication 24 November 2018

Published 11 February 2019 Volume 2019:11 Pages 17—22

DOI https://doi.org/10.2147/HIV.S184603

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Professor Bassel Sawaya


Video abstract presented by Saro Abdella Abrahim.

Views: 94

Saro Abdella Abrahim, Mulu Girma, Abebe Habteselassie, Nigussie Gezahegn, Altaye Feleke, Tezera Moshago Berheto, Minilik Demissie, Wudnesh Belete, Tekalign Deressa

HIV/TB Research and Reference Laboratory Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia

Purpose: Genetic diversities in different countries affect the performance of HIV test kits. Therefore, WHO recommends evaluation of every HIV test kit in countries’ context before its use. Therefore, this study aimed to evaluate the performance of Genscreen ULTRA HIV Ag–Ab and Bioelisa.
Materials and methods: The study had used 400 characterized plasma samples obtained from CDC Atlanta bio-bank derived from Africa, USA, and Thailand.
Results: Diagnostic performance of both test kits under evaluation was assessed at 95% CI. Genscreen ULTRA HIV Ag–Ab had sensitivity and negative predictive value of 99.5% [95% CI, 97.2–99.9] and the specificity and positive predictive value of 98.5% [95% CI, 95.7–99.7]. Bioelisa HIV test kit had exhibited sensitivity and negative predictive value of 99% [95% CI, 96.4–99.7] and specificity and positive predictive value of 98.5% [95% CI, 95.7–99.7]. Both test kits were able to detect almost all samples with HIV-2, dual infections, and seroconversion.
Conclusion: Both the test kits were highly sensitive and specific in detecting HIV. However, there are still few samples containing HIV antibody which were not identified by both kits. Therefore, additional screening measures should be done in using these assays for blood transfusion and organ transplantation. In addition, the study can be used as a reference by other African countries.

Keywords: ELISA, sensitivity, positive predictive, specificity, validation
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]